ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.

85,013 comparisons

Most participants first33,758 with no events in either group come last1,801 to 1,820 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
Arm B (Short Term Storage) vs Standard of Care (Long Term Storage): Persistent Organ Dysfunction Combined With Death Measured at Day 28573 of 2,457

549 of 2,462

1.0 points

-1.3 to 3.4

4,919NCT01638416

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial

Arm B (Short Term Storage) vs Standard of Care (Long-term Storage): Blood Stream Infection in ICU (Post Randomisation)123 of 2,457

88 of 2,462

1.4 points

0.3 to 2.6

4,919NCT01638416

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial

Arm B (Short Term Storage) vs Standard of Care (Long Term Storage): Mortality at Day 28476 of 2,457

463 of 2,462

0.6 points

-1.6 to 2.8

4,919NCT01638416

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial

Arm B (Short Term Storage) vs Standard of Care (Long-term Storage): Proportion of Patients Who Suffer at Least One Febrile Non-haemolytic Transfusion Reaction in ICU35 of 2,457

39 of 2,462

-0.2 points

-0.9 to 0.5

4,919NCT01638416

Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial

Routine Thermal Management vs Aggressive Thermal Management: Readmission135 of 2,447

161 of 2,462

-1.0 points

-2.4 to 0.3

4,909NCT03111875

Perioperative Hypothermia and Myocardial Injury After Non-cardiac Surgery

Interactive Two-way SMS Dialogue vs No SMS Control: Early Neonatal Mortality38 of 2,450

28 of 2,447

0.4 points

-0.2 to 1.1

4,897NCT04598165

Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support

Pre-VAP Diagnostic Stewardship vs VAP Diagnostic Stewardship: deaths from any cause1,666 of 4,205

284 of 687

-1.7 points

-5.7 to 2.2

4,892NCT05176353

Ventilator-associated Pneumonia (VAP) Diagnostic Stewardship Trial

Pre-VAP Diagnostic Stewardship vs VAP Diagnostic Stewardship: serious adverse events278 of 4,205

34 of 687

1.7 points

-0.4 to 3.3

4,892NCT05176353

Ventilator-associated Pneumonia (VAP) Diagnostic Stewardship Trial

LAMA vs ICS/LABA: Number of Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Events1,170 of 2,444

1,285 of 2,444

-4.7 points

-7.5 to -1.9

4,888NCT04172701

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

LAMA vs ICS/LABA: Number of Patients With Lung Cancer57 of 2,444

53 of 2,444

0.2 points

-0.7 to 1.0

4,888NCT04172701

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

LAMA vs ICS/LABA: Number of Patients With Tuberculosis (TB)56 of 2,444

47 of 2,444

0.4 points

-0.4 to 1.2

4,888NCT04172701

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

LAMA vs ICS/LABA: Number of Patients With the Event All-cause Death51 of 2,444

46 of 2,444

0.2 points

-0.6 to 1.0

4,888NCT04172701

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

LAMA vs ICS/LABA: Number of Patients With Pneumonia Event501 of 2,444

605 of 2,444

-4.3 points

-6.6 to -1.9

4,888NCT04172701

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

LAMA vs ICS/LABA: Number of Patients With Non-tuberculosis Mycobacteria (NTM) Lung Disease27 of 2,444

14 of 2,444

0.5 points

0.0 to 1.1

4,888NCT04172701

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

LAMA vs ICS/LABA: deaths from any cause51 of 2,444

46 of 2,444

0.2 points

-0.6 to 1.0

4,888NCT04172701

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

LAMA vs ICS/LABA: Number of Patients Who Initiated a Triple Combination Therapy383 of 2,444

518 of 2,444

-5.5 points

-7.7 to -3.4

4,888NCT04172701

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

Interactive Two-way SMS Dialogue vs No SMS Control: Neonatal Mortality46 of 2,442

37 of 2,442

0.4 points

-0.4 to 1.1

4,884NCT04598165

Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support

Clopidogrel vs Placebo: Major Hemorrhage Other Than Intracranial Hemorrhage17 of 2,432

7 of 2,449

0.4 points

0.0 to 0.9

4,881NCT00991029

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Clopidogrel vs Placebo: Symptomatic Intracerebral Hemorrhage2 of 2,432

2 of 2,449

0.0 points

-0.2 to 0.2

4,881NCT00991029

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Clopidogrel vs Placebo: Composite of Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes121 of 2,432

160 of 2,449

-1.6 points

-2.9 to -0.2

4,881NCT00991029

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=91

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01638416-140a3d5a",
        "title": "Arm B (Short Term Storage) vs Standard of Care (Long Term Storage): Persistent Organ Dysfunction Combined With Death Measured at Day 28",
        "summary": "573 of 2457 against 549 of 2462; risk difference 1.0 points, 95% interval -1.3 to 3.4; NCT01638416, Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial",
        "record": "/library/comparisons/NCT01638416-140a3d5a",
        "nct_id": "NCT01638416",
        "kind": "outcome",
        "participants": 4919,
        "risk_difference": {
          "value": 0.010221793731135742,
          "lower": -0.01323152314105007,
          "upper": 0.03366384400379389
        },
        "group_1": "573 of 2,457",
        "group_2": "549 of 2,462",
        "difference": "1.0 points",
        "interval": "-1.3 to 3.4",
        "trial_title": "Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial"
      },
      {
        "id": "NCT01638416-4be6e3df",
        "title": "Arm B (Short Term Storage) vs Standard of Care (Long-term Storage): Blood Stream Infection in ICU (Post Randomisation)",
        "summary": "123 of 2457 against 88 of 2462; risk difference 1.4 points, 95% interval 0.3 to 2.6; NCT01638416, Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial",
        "record": "/library/comparisons/NCT01638416-4be6e3df",
        "nct_id": "NCT01638416",
        "kind": "outcome",
        "participants": 4919,
        "risk_difference": {
          "value": 0.014317751929449736,
          "lower": 0.002983365741377293,
          "upper": 0.025783062233339808
        },
        "group_1": "123 of 2,457",
        "group_2": "88 of 2,462",
        "difference": "1.4 points",
        "interval": "0.3 to 2.6",
        "trial_title": "Standard Issue Transfusion Versus Fresher Red Blood Cell Use in Intensive Care- A Randomised Controlled Trial"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=92",
  "request_id": "OmI1NkFgPNahVtTt"
}
trial-comparisons-2026-03-23-0.1.0Next page

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Open193,990 genes2026-11-11

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?